Header Logo

Connection

Joan Walker to Phosphatidylinositol 3-Kinases

Back to Details
This is a "connection" page, showing publications Joan Walker has written about Phosphatidylinositol 3-Kinases.
Joan Walker
Connection Strength
0.047
Phosphatidylinositol 3-Kinases
  1. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol. 2022 03; 164(3):481-491.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.